BDX
Price
$234.12
Change
+$1.80 (+0.77%)
Updated
Dec 11, 11:25 AM EST
57 days until earnings call
BSX
Price
$54.93
Change
-$0.10 (-0.18%)
Updated
Dec 8, 6:59 PM EST
51 days until earnings call
Ad is loading...

Compare trend and price BDX vs BSX

Header iconBDX vs BSX Comparison
Open Charts BDX vs BSXBanner chart's image
Becton Dickinson and
Price$234.12
Change+$1.80 (+0.77%)
Volume$2.27K
CapitalizationN/A
Boston Scientific
Price$54.93
Change-$0.10 (-0.18%)
Volume$1.53M
CapitalizationN/A
View a ticker or compare two or three
BDX vs BSX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BDX vs. BSX commentary
Dec 11, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Hold and BSX is a Hold.

COMPARISON
Comparison
Dec 11, 2023
Stock price -- (BDX: $232.30 vs. BSX: $54.95)
Brand notoriety: BDX: Not notable vs. BSX: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BDX: 110% vs. BSX: 56%
Market capitalization -- BDX: $68.91B vs. BSX: $81.58B
BDX [@Medical Specialties] is valued at $68.91B. BSX’s [@Medical Specialties] market capitalization is $81.58B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green whileBSX’s FA Score has 1 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • BSX’s FA Score: 1 green, 4 red.
According to our system of comparison, BDX is a better buy in the long-term than BSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 5 TA indicator(s) are bullish while BSX’s TA Score has 4 bullish TA indicator(s).

  • BDX’s TA Score: 5 bullish, 4 bearish.
  • BSX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BDX is a better buy in the short-term than BSX.

Price Growth

BDX (@Medical Specialties) experienced а -2.10% price change this week, while BSX (@Medical Specialties) price change was -2.12% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.78%. For the same industry, the average monthly price growth was +12.04%, and the average quarterly price growth was -10.13%.

Reported Earning Dates

BDX is expected to report earnings on Feb 06, 2024.

BSX is expected to report earnings on Jan 31, 2024.

Industries' Descriptions

@Medical Specialties (-0.78% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for BDX with price predictions.
OPEN
A.I.dvisor published
a Summary for BSX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BSX($81.6B) has a higher market cap than BDX($68.9B). BSX has higher P/E ratio than BDX: BSX (67.11) vs BDX (46.51). BSX YTD gains are higher at: 18.759 vs. BDX (-7.272). BDX has higher annual earnings (EBITDA): 4.53B vs. BSX (3.32B). BSX (952M) and BDX (931M) have equal amount of cash in the bank . BSX has less debt than BDX: BSX (9.3B) vs BDX (16.8B). BDX has higher revenues than BSX: BDX (19B) vs BSX (13.8B).
BDXBSXBDX / BSX
Capitalization68.9B81.6B84%
EBITDA4.53B3.32B136%
Gain YTD-7.27218.759-39%
P/E Ratio46.5167.1169%
Revenue19B13.8B138%
Total Cash931M952M98%
Total Debt16.8B9.3B181%
FUNDAMENTALS RATINGS
BDX vs BSX: Fundamental Ratings
BDX
BSX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
6827
SMR RATING
1..100
8281
PRICE GROWTH RATING
1..100
6235
P/E GROWTH RATING
1..100
4386
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDX's Valuation (11) in the Medical Specialties industry is significantly better than the same rating for BSX (83). This means that BDX’s stock grew significantly faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (27) in the Medical Specialties industry is somewhat better than the same rating for BDX (68). This means that BSX’s stock grew somewhat faster than BDX’s over the last 12 months.

BSX's SMR Rating (81) in the Medical Specialties industry is in the same range as BDX (82). This means that BSX’s stock grew similarly to BDX’s over the last 12 months.

BSX's Price Growth Rating (35) in the Medical Specialties industry is in the same range as BDX (62). This means that BSX’s stock grew similarly to BDX’s over the last 12 months.

BDX's P/E Growth Rating (43) in the Medical Specialties industry is somewhat better than the same rating for BSX (86). This means that BDX’s stock grew somewhat faster than BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDXBSX
RSI
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
53%
Bearish Trend 4 days ago
51%
Momentum
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
59%
MACD
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
47%
Bearish Trend 4 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
44%
Bullish Trend 4 days ago
56%
Advances
ODDS (%)
Bullish Trend 11 days ago
50%
Bullish Trend 11 days ago
58%
Declines
ODDS (%)
Bearish Trend 6 days ago
44%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
67%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
31%
Bullish Trend 4 days ago
56%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OB4.070.21
+5.44%
Outbrain
TTEC20.260.37
+1.86%
TTEC Holdings
MLM469.394.06
+0.87%
Martin Marietta Materials
SBRA14.14-0.07
-0.49%
Sabra Health Care REIT
ARVL1.26-0.01
-0.79%
Arrival

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been loosely correlated with SYK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
-0.15%
SYK - BSX
66%
Loosely correlated
-0.10%
ZBH - BSX
58%
Loosely correlated
+0.01%
ISRG - BSX
55%
Loosely correlated
-0.37%
RVTY - BSX
52%
Loosely correlated
-0.72%
MDT - BSX
51%
Loosely correlated
-0.25%
More